When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Nurix Therapeutics (NRIX) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.
The company is developing small molecule-based treatments for blood cancers and immune system conditions.
NRIX is a promising biopharma with substantial major pharma partnerships, but has yet to enter Phase 1 safety trials for its lead candidate, so the firm and IPO is ultra high risk.
I’ll provide a final opinion when we learn more about the IPO from management.